Chris Painter
Health Economist
Chris Painter’s research focuses on using health economics and health technology assessment methods to inform resource allocation policy decisions for a wide range of communicable and non-communicable diseases. This typically involves a comparison between the economic costs and health impacts of different health interventions to understand which intervention(s) are most cost-effective to use in practice.
A Health Economist at MORU MAEMOD’s Neglected Tropical Diseases Modeling (NTDM) Group since 2022, Chris’ current work focusses on: (ACORN) A Clinically Oriented antimicrobial Resistance Network; the ACT-South Asia (Azithromycin and Cefixime treatment of typhoid in South Asia) trial; and working with LOMWRU, MORU’s Lao PDR Unit, on the newly formed Unit for Health Evidence and Policy (UHEP) in Vientiane.
Chris’ ongoing research interests include antimicrobial resistance (AMR); COVID-19; Hepatitis C virus; and health economics and health technology assessment methods and institutionalising these methods in low- and middle-income countries (LMICs)
Holder of both an MSc and a BSc Economics from the University of Manchester, prior to MORU Chris worked as a health economist in the UK private sector and as an Overseas Development Institute Fellow (2019-2022) at the Health Intervention and Technology Assessment Program (HITAP) in Thailand’s Ministry of Public Health.
Recent publications
-
Cost-effectiveness analysis of a multiplex lateral flow rapid diagnostic test for acute non-malarial febrile illness in rural Cambodia and Bangladesh.
Journal article
Chew R. et al, (2024), The Lancet regional health. Southeast Asia, 23
-
Cost-effectiveness analysis of surgical masks, N95 masks compared to wearing no mask for the prevention of COVID-19 among health care workers: Evidence from the public health care setting in India.
Journal article
Sharma M. et al, (2024), PloS one, 19
-
A systematic literature review of economic evaluation studies of interventions impacting antimicrobial resistance.
Journal article
Painter C. et al, (2023), Antimicrobial resistance and infection control, 12
-
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
Journal article
Wang Y. et al, (2023), The European journal of health economics : HEPAC : health economics in prevention and care, 24, 735 - 748
-
How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic.
Journal article
Luangasanatip N. et al, (2023), Vaccine, 41, 4854 - 4860